104 results
8-K
EX-99.1
VANI
Vivani Medical Inc
4 Sep 19
Regulation FD Disclosure
9:00am
be identified by words such as "estimates," "anticipates," "projects," "plans" or "planned," "strategy," “goal," "seeks," "may," "will," "expects," "intends … to be larger
Growth Strategy Centered on Orion® Orion Core Competencies Research Execute Orion clinical and R&D programs Positive six- and 12-month results
8-K
EX-99.1
VANI
Vivani Medical Inc
6 Aug 19
Second Sight Reports Second Quarter 2019 Financial Results
4:16pm
, reduced headcount and related compensation expenses in connection with the strategy shift to Orion. The Company is on track with its expense reduction … a comprehensive reimbursement strategy for Orion in the U.S.;
Submit Argus 2s, our next-gen externals, to the FDA for U.S. regulatory approval
8-K
EX-99.1
VANI
Vivani Medical Inc
14 Nov 19
Second Sight Reports Third Quarter 2019 Financial Results
4:15pm
reimbursement strategy for Orion in the U.S.;
Submit Argus 2s, our next-gen externals, to the FDA for U.S. regulatory approval by year end; and
Add … .” These statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,” “goal,” or “planned,” “seeks,” “may
8-K
EX-99.1
VANI
Vivani Medical Inc
12 Mar 20
Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO
4:35pm
the implementation of our strategy to focus on the development and advancement of our breakthrough Orion® Visual Cortical Prosthesis System. I also look … are “forward looking statements.” These statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,” “goal
8-K
EX-99.1
VANI
Vivani Medical Inc
15 May 19
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
4:31pm
Feasibility Study and Significant Market Potential Drive Refined Strategy --
-- Company to Provide Continued Support for Existing Argus® II Users … .” These statements may be identified by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,” “goal,” or “planned,” “seeks,” “may
8-K
EX-99.1
7n1b5sqx668x3n
8 May 18
Second Sight Completes $10 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
6:12am
8-K
EX-99.1
kb2 dd0lt6
30 Mar 20
Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO
3:52pm
8-K
EX-99.1
k9v6dt7 u5ppic
25 Sep 20
Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA
6:02am
8-K
EX-99.1
mzozts v4pk6xsghyl36
15 May 19
Second Sight Reports First Quarter 2019 Financial Results
4:54pm
8-K
EX-99.1
xfb392nd66bvjo 1e
5 May 20
Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock
1:16pm
8-K
EX-99.1
pejr eqepcg07p1od9re
28 Apr 20
Second Sight Medical Products Provides Business Update
8:15am
8-K
EX-99.1
2wow3gugksyvq06d9j
1 May 20
Second Sight Medical Products Announces Pricing of Public Offering of Common Stock
6:02am
8-K
EX-99.1
is8d4
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm
8-K
EX-99.1
dpis30c0g6n m4opl
23 Sep 22
Regulation FD Disclosure
6:04am
8-K
EX-99.1
90ivsms05s6o86
17 Oct 22
Regulation FD Disclosure
6:45am
8-K
EX-99.1
l2aq9
15 May 23
Results of Operations and Financial Condition
6:49am
8-K
EX-99.2
3jcd2t
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
8-K
gnwidk1y
3 Jan 20
Material Modifications to Rights of Security Holders
6:02am
8-K
EX-99.1
z9f0uyzd
18 Sep 23
Regulation FD Disclosure
6:20am
FWP
k87htlbp
29 Apr 20
Free writing prospectus
6:09am